Model‐based lamotrigine clearance changes during pregnancy: clinical implication-Reference-Cited by-同舟云学术

Model‐based lamotrigine clearance changes during pregnancy: clinical implication

Published:2014-01-09 Issue:2 Volume:1 Page:99-106
ISSN:2328-9503
Container-title:Annals of Clinical and Translational Neurology
language:en
Short-container-title:Ann Clin Transl Neurol

Author:

Polepally Akshanth R.¹,Pennell Page B.²,Brundage Richard C.¹,Stowe Zachary N.³,Newport Donald J.⁴⁵,Viguera Adele C.⁶,Ritchie James C.⁵⁷,Birnbaum Angela K.¹

Affiliation:

1. Experimental and Clinical Pharmacology College of Pharmacy University of Minnesota Minneapolis Minnesota

2. Department of Neurology and Division of Women's Health at Brigham and Women's Hospital Harvard Medical School Boston Massachusetts

3. Departments of Psychiatry, Pediatrics, and Obstetrics & Gynecology University of Arkansas for Medical Sciences Little Rock Arkansas

4. Departments of Psychiatry and Obstetrics & Gynecology The Ohio State University College of Medicine Columbus Ohio

5. Department of Psychiatry and Behavioral Sciences Emory University School of Medicine Atlanta Georgia

6. Department of Psychiatry Cleveland Clinic Cleveland Ohio

7. Department of Pathology Emory University School of Medicine Atlanta Georgia

Publisher

Wiley

Subject

Neurology (clinical),General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/acn3.29

Reference42 articles.

1. Lamotrigine in bipolar disorder: efficacy during pregnancy

2. Epilepsy and pregnancy: lamotrigine as main drug used

3. Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study

4. Teratogenic effects of antiepileptic drugs

5. Comparative safety of antiepileptic drugs during pregnancy

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PBPK Modeling of Lamotrigine and Efavirenz during Pregnancy: Implications for Personalized Dosing and Drug-Drug Interaction Management;Pharmaceutics;2024-09-03

2. Advances in Psychotropic Treatment for Pregnant Women: Efficacy, Adverse Outcomes, and Therapeutic Monitoring;Journal of Clinical Medicine;2024-07-27

3. Safe delivery, perinatal outcomes and breastfeeding in women with epilepsy;Epilepsy & Behavior;2024-07

4. The impact of pregnancy-related hormonal and physiological changes on antiseizure medications: expert perspective;Expert Review of Clinical Pharmacology;2024-05-21

5. Physiologically Based Pharmacokinetic Modelling of UGT Substrate Drugs Lamotrigine and Raltegravir during Pregnancy;Future Pharmacology;2024-04-10